Evaluating the Effect of Standard-of-care Erythropoiesis-stimulating Agents on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease.

NCT02987465 · clinicaltrials.gov ↗

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
Chronic Kidney Disease

Interventions

DRUG: Darbepoetin Alfa
DRUG: Acetylcholine
DRUG: Noradrenaline
DRUG: BQ 123

Sponsor

Cambridge University Hospitals NHS Foundation Trust

Collaborators

[object Object]